HONG KONG (Reuters) – Hong Kong authorities said on Thursday they would resume the use of a COVID-19 vaccine from Germany’s BioNTech next Monday after abruptly halting inoculations 9 days ago due to defective packaging.
The announcement comes as the city’s government tries to convince residents in the Chinese special administrative region to get vaccinated after a sluggish take-up due to dwindling confidence in China’s Sinovac vaccine and fears of adverse reactions.
(Reporting by the Hong Kong newsroom; editing by Jason Neely)
